
Oncology NEWS International
- Oncology NEWS International Vol 17 No 5
- Volume 17
- Issue 5
Spotlight on Cancer Centers
The recently opened Institute of Cancer “Octavio Frias de Oliveira,” in Brazil’s capital of São Paulo, is a state institution that will care for cancer patients from São Paulo as well as neighboring states, according to information provided by ONI Editorial Advisory Board member Paulo Hoff, MD, of The Medical School of the University of São Paulo.
The recently opened Institute of Cancer “Octavio Frias de Oliveira,” in Brazil’s capital of So Paulo, is a state institution that will care for cancer patients from So Paulo as well as neighboring states, according to information provided by ONI Editorial Advisory Board member Paulo Hoff, MD, of The Medical School of the University of So Paulo.
The new cancer center is named after Octavio Frias de Oliveira, who built a media empire in Brazil and was publisher of Folha de So Paulo, Brazil’s largest newpaper. Mr. Frias died last year at age 94.
Managed by medical school
With 580 beds, the new hospital will be managed by The Medical School of the University of So Paulo, the premier medical school in Brazil.
The Institute will focus on medical care, education, and research. The objective is to position the Institute as one of the main research centers in the world.
When operating at full capacity, it is estimated that the Institute will deliver care to approximately 16,000 new patients every year. It occupies a 28-floor building, with 540,000 square feet dedicated to cancer care and research.
Articles in this issue
over 17 years ago
Immunotherapy agent promising in NSCLCover 17 years ago
NCCN greenlights nilotinib for imatinib-resistant CML patientsover 17 years ago
No overall survival benefit for dose-intense regimen in SCLCover 17 years ago
Make a note of new smoking cessation codesover 17 years ago
Relistor for treating OICover 17 years ago
Experts argue against need for phase III proton Rx trialsover 17 years ago
Novel peptide vaccine promising in myeloid leukemiaover 17 years ago
Intensive imatinib/chemo ups EFS in pediatric Ph+ ALLover 17 years ago
Relapsing DLBCL patients respond to rituximab-based RxNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.


















































































